(Q38980944)

8 September 2017

title

Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2. (English)

1 reference

8 September 2017

1 reference

Hongyu Guan

1

1 reference

8 September 2017

Weiwei Liang

2

1 reference

8 September 2017

Zhiwei Xie

3

1 reference

8 September 2017

Hai Li

4

1 reference

8 September 2017

Juan Liu

5

1 reference

8 September 2017

Liehua Liu

6

1 reference

8 September 2017

Lingling Xiu

7

1 reference

8 September 2017

Yanbing Li

8

1 reference

8 September 2017

publication date

27 June 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

48

1 reference

8 September 2017

issue

2

1 reference

8 September 2017

page(s)

566-574

1 reference

Progress in molecular-based management of differentiated thyroid cancer

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

microRNAs: tiny regulators with great potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

MicroRNAs: key participants in gene regulatory networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

MicroRNAs in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

The role of microRNA genes in papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Effects of let-7 microRNA on Cell Growth and Differentiation of Papillary Thyroid Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Modulation of the osteosarcoma expression phenotype by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Effect of BRAFV600E mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Expression of the ZEB1 (deltaEF1) transcription factor in human: additional insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Down-regulation of miR-218-2 and its host gene SLIT3 cooperate to promote invasion and progression of thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

MicroRNA targets in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

mRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

Knockdown of BAG3 induces epithelial-mesenchymal transition in thyroid cancer cells through ZEB1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0326-7

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968735

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24968735

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

MicroRNAs as oncogenes and tumor suppressors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24968735

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12020-014-0326-7

1 reference

8 September 2017

1 reference